After a two-decade stint with Pfizer India, Kewal Handa, managing director, is hanging up his boots in August.
Hyderabad-based road and real estate developer IVRCL, which is under a takeover threat from Subhash Chandra-promoted Essel Group, is looking…
Pramod Hari Lele, 63, chief executive of city-based PD Hinduja Hospital, recently decided to gift a little more than just…
Healthcare chains are looking to raise money to grow by building and buying assets as demand-supply gap widens in the…
Jawaharlal Nehru Port Trust, which operates India?s largest container port, needs to urgently increase its capacity and deepen its channel…
A diversification into engineering, procurement and construction or EPC has paid off for IOT Infrastructure & Energy Services…
Yusuf Khwaja Hamied, 75, chairman and managing director of the R6,135-crore pharmaceutical major Cipla…
With crude oil prices hovering above the $120-mark, public sector oil marketing companies (OMCs) IndianOil (IOC)…
Pharmaceutical company Lupin aims to nearly triple its revenues over the next three years as it eyes a growth of…
For oil marketing companies (OMCs) squeezed by losses from selling fuel below cost, necessity has become the mother of innovation….
Bangalore-based Strides Arcolab, which sold off its generic drug business in Australia and Southeast Asia to American Watson Pharma for…
Call it the collateral damage of saving domestic airlines.
In a bid to gain from the emerging market group, Bristol-Myers Squibb India plans to launch patented medicines for diabetes,…
India?s largest engineering and construction company Larsen & Toubro is planning to double its sales to R1 lakh crore by…
As Tata Group chairman Ratan Tata grooms his successor Cyrus Mistry before passing on the baton this December, he leaves…
For Glen Saldanha, 41, pieces in a business puzzle are falling in place a decade after he took over the…
India?s second largest government-run oil refiner and marketer Bharat Petroleum Corporation plans to derisk its business through its oil and…
It?s been no easy ride for Novartis India, formed in 1997 through the merger of Hindustan Ciba-Geigy and Sandoz.
